NP
GILD icon

NS Partners’s Gilead Sciences GILD Stock Holding History

NS Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-51,022
Closed -$3.65M – 102
2017
Q4 		$3.65M Buy
51,022
+182
+0.4% +$13.8K 0.4% 78
2017
Q3 		$4.12M Buy
50,840
+17,196
+51% +$1.31M 0.49% 71
2017
Q2 		$2.38M Sell
33,644
-16,885
-33% -$1.12M 0.31% 77
2017
Q1 		$3.43M Sell
50,529
-144
-0.3% -$10.1K 0.49% 73
2016
Q4 		$3.63M Sell
50,673
-245
-0.5% -$18.2K 0.57% 75
2016
Q3 		$4.03M Sell
50,918
-545
-1% -$44.3K 0.66% 68
2016
Q2 		$4.29M Buy
51,463
+1,065
+2% +$94.5K 0.73% 59
2016
Q1 		$4.63M Sell
50,398
-17,712
-26% -$1.6M 0.83% 53
2015
Q4 		$6.89M Sell
68,110
-5,225
-7% -$544K 1.23% 27
2015
Q3 		$7.2M Sell
73,335
-869
-1% -$96.5K 1.26% 25
2015
Q2 		$8.69M Buy
+74,204
New +$8.11M 1.38% 21

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NS Partners's GILD Position: Q1 2018 in Review

NS Partners sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 51,022 shares — an estimated $3.65M sold.

NS Partners first reported a position in GILD in Q2 2015 and held it in 11 quarters. The position peaked at $8.69M in Q2 2015. 1,564 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • NS Partners reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
  • NS Partners sold 51,022 Gilead Sciences shares in Q1 2018, an estimated $3.65M.
  • NS Partners first reported a position in Gilead Sciences in Q2 2015 and held it in 11 quarters.
  • NS Partners's Gilead Sciences position peaked at $8.69M in Q2 2015.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on NS Partners's 13F filing for Q1 2018, filed 15 May 2018.